Stem-Cell Research Backed by a Company Advances to First Human Therapy Test

In the last days of July, the Food and Drug Administration gave the green light to a clinical trial that has been nearly a decade in the making. The federal agency approved a test of some of the first fruits of human-embryonic-stem-cell research, in a new therapy that could help patients recover from spinal-cord injury.